ArticleClinical pharmacology and therapeutics2018

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

Daniel M Rotroff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.